Americans suffering from arthritis can now find relief from an unexpected new player in the pharmaceuticals market.
South Korea’s Samsung conglomerate, best known for its smartphones and televisions, will make available on Monday in the U.S. its lower-price copy of Johnson & Johnson’s blockbuster rheumatoid-arthritis drug Remicade, the second such alternative on the market. The Samsung-developed drug will be marketed to…
from WSJ.com: What’s News US http://ift.tt/2v1P9gP
via IFTTT